Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial. Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, et al. Nat Med 2025 Aug 14. doi: 10.1038/s41591-025-03875.

Read + Share

Amedeo Smart

Independent Medical Education

Kendra KL, Bellasea SL, Eroglu Z, Hu-Lieskovan S, et al. Anti-PD-1 therapy in unresectable desmoplastic melanoma: the phase 2 SWOG S1512 trial. Nat Med 2025 Aug 14. doi: 10.1038/s41591-025-03875.
PMID: 40813711